- Free from Publisher SM Strowig, P Raskin - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Both groups experienced a significant reduction in HbA 1c (A1C) level
(rosiglitazone: 7.9 ± 1.3 to 6.9 ± 0.7%, P < 0.0001; placebo: 7.7 ± 0.8 to
7.0 ± 0.9%, P = 0.002) and a significant increase in weight ... Cited by 25 - Related articles - BL Direct - All 6 versions
V Zdravkovic, JK Hamilton, D Daneman, EA … - The Journal of pediatrics, 2006 - Elsevier Metabolic control (A1c) was improved at 6 months in all subjects (P = .02).
There was no significant difference between the pioglitazone and placebo
treatment groups at 6 months in either change in A1c (−0.4% ± 0.9% and ... Cited by 10 - Related articles - All 3 versions
- ►diabetesjournals.org J Hamilton, E Cummings, V Zdravkovic, D … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—At t = 0, HbA 1c was 9.2 ± 0.9%, insulin dosage was 1.2 ± 0.2 units
· kg − 1 · day − 1 , fasting glucose was 10.6 ± 2.4 mmol/l, and BMI was
24.2 ± 3.9 kg/m 2 (means ± SD), with no difference between the metformin ... Cited by 70 - Related articles - BL Direct - All 6 versions
- ►eje.org [PDF] S Sarnblad, M Kroon, J Aman - European Journal of Endocrinology, 2003 - eje.org Objective: Metabolic control often deteriorates during puberty in children with
type 1 diabetes. The aim of the present study was to investigate whether
addition of metformin for 3 months improves metabolic control and insulin ... Cited by 34 - Related articles - BL Direct - All 7 versions
S Makimattila, A Virkamaki, R Malmstrom, T … - Journal of Clinical Endocrinology & Metabolism, 1996 - Endocrine Soc Page 1. 0021-972x/96/$03.00/0 Journal of Clinical Endocrinology and Metabolism
Copyright 0 1996 by The Endocrine Society Vol. 81, No. 2 PrtntQd Ln USA ... Cited by 36 - Related articles - All 5 versions
- Free from Publisher L Meyer, P Bohme, I Delbachian, P Lehert, N … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Treatment with metformin was associated with a reduction in daily
insulin requirements between V0 and V6 of −4.3 ± 9.9 units (−7.8 ± 18%)
compared with an increase with placebo treatment of 1.7 ± 8.3 units (2.8 ... Cited by 19 - Related articles - BL Direct - All 5 versions
[CITATION] Insulin sensitivity measured with euglycaemic clamp technique in newly diagnosed diabetes …
A Szadkowska, I Pietrzak… - Medycyna wieku rozwojowego - ncbi.nlm.nih.gov The aim of this study was to estimate insulin resistance in newly diagnosed type
1 diabetic children and adolescents and to analyse the correlation between
insulin secretion and impaired insulin action. 37 patients with type 1 ... Cited by 4 - Related articles
- ►diabetesjournals.org [PDF] JD Faichney, PW Tate - Diabetes care, 2003 - Am Diabetes Assoc Our objective was to evaluate the di- agnostic proficiency of the World Health
Organization (WHO) and the National Cholesterol Education Pro- gram (NCEP)-III
definitions (1,2) for the metabolic syndrome in a Mexican nation- wide, ... Cited by 4 - Related articles - BL Direct - All 5 versions
AS Khan, CR McLoughney, AB Ahmed - DIABETIC MEDICINE-CHICHESTER-, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 14 - Related articles - BL Direct - All 5 versions
